T

Teyi Pharmaceutical Group Co Ltd
SZSE:002728

Watchlist Manager
Teyi Pharmaceutical Group Co Ltd
SZSE:002728
Watchlist
Price: 9.27 CNY -1.38% Market Closed
Market Cap: 4.7B CNY
Have any thoughts about
Teyi Pharmaceutical Group Co Ltd?
Write Note

Gross Margin
Teyi Pharmaceutical Group Co Ltd

43.3%
Current
51%
Average
48.4%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
43.3%
=
Gross Profit
336.8m
/
Revenue
777.5m

Gross Margin Across Competitors

Country CN
Market Cap 4.7B CNY
Gross Margin
43%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 749.1B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 2.7T DKK
Gross Margin
85%
Country US
Market Cap 348B USD
Gross Margin
69%
Country US
Market Cap 251.1B USD
Gross Margin
77%
Country CH
Market Cap 200.1B CHF
Gross Margin
73%
Country UK
Market Cap 161.8B GBP
Gross Margin
82%
Country CH
Market Cap 171.5B CHF
Gross Margin
75%
Country US
Market Cap 150.1B USD
Gross Margin
71%
No Stocks Found

Teyi Pharmaceutical Group Co Ltd
Glance View

Market Cap
4.7B CNY
Industry
Pharmaceuticals

Teyi Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and pharmaceutical health industry. The company is headquartered in Jiangmen, Guangdong and currently employs 1,200 full-time employees. The company went IPO on 2014-07-31. The firm primarily provides Chinese traditional patent medicines, including cough arresting and phlegm removing medicine series, kidney reinforcing medicine series and anti-infection medicine series, among others. The firm's products mainly include tablets, granules, medicinal tea, syrup, decocted extracts, capsules, powder, ointment, cream, as well as oral solutions, among others.

Intrinsic Value
11.66 CNY
Undervaluation 21%
Intrinsic Value
Price
T

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
43.3%
=
Gross Profit
336.8m
/
Revenue
777.5m
What is the Gross Margin of Teyi Pharmaceutical Group Co Ltd?

Based on Teyi Pharmaceutical Group Co Ltd's most recent financial statements, the company has Gross Margin of 43.3%.